The cell death response observed in neuroblastoma was more potent and consistent across cell lines compared to other solid tumor models, again suggesting that neuroblastoma cell lines are more broadly sensitive to BET inhibition (Figure S6A in File S1). The gene discussed is DNER; the disease is neuroblastoma.